| Ketones bodies as potential key regulator in the cardiovascular-kidney-metabolic syndrome | |  | | 2026 | 8 | 0 |
|
| Dépister et ralentir l’apparition du diabète de type 1 : un nouveau paradigme | Revue médicale suisse |  | | 2025 | 35 | 0 |
|
| Quelle diète pour la néphroprotection dans la maladie rénale chronique ? | Revue médicale suisse |  | | 2025 | 123 | 2 |
|
| Case Report : Extreme resistance to subcutaneous insulin in a cirrhotic patient with new-onset diabetes that resolved after transplantation | Frontiers in endocrinology |  | | 2025 | 41 | 192 |
|
| Self-reported perceptions of adults with diabetes regarding their care and health in the time of COVID-19 pandemic in a Swiss region : a cross-sectional study | Swiss medical weekly |  | | 2024 | 24 | 55 |
|
| Effects of empagliflozin on reproductive system in men without diabetes | Scientific reports |  | | 2024 | 60 | 111 |
|
| Mesures du glucose non invasives : où en est-on ? | Revue médicale suisse |  | | 2024 | 85 | 4 |
|
| Pied diabétique : une prise en charge complexe et multidisciplinaire | Revue médicale suisse |  | | 2023 | 134 | 48 |
|
| Cardio-Metabolic and Mental Health Outcomes Before and During the COVID-19 Pandemic in a Cohort of Women With Gestational Diabetes Mellitus in Switzerland | Frontiers in endocrinology |  | | 2022 | 12 | 39 |
|
| Impact of Risk Factors on Short and Long-Term Maternal and Neonatal Outcomes in Women With Gestational Diabetes Mellitus : A Prospective Longitudinal Cohort Study | Frontiers in endocrinology |  | | 2022 | 14 | 38 |
|
| Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on β-Cell Function at 1 Year After Surgery : A Systematic Review | The Journal of clinical endocrinology and metabolism |  | | 2022 | 17 | 179 |
|
| Efficacy of Ketogenic Diets on Type 2 Diabetes : a Systematic Review | Current diabetes report |  | | 2021 | 14 | 277 |
|
| A Single Load of Fructose Attenuates the Risk of Exercise-Induced Hypoglycemia in Adults With Type 1 Diabetes on Ultra-Long-Acting Basal Insulin : A Randomized, Open-Label, Crossover Proof-of-Principle Study | Diabetes care |  | | 2020 | 16 | 57 |
|